ARRY
Price
$9.01
Change
-$0.10 (-1.10%)
Updated
Aug 29 closing price
Capitalization
1.38B
67 days until earnings call
INO
Price
$2.37
Change
-$0.09 (-3.66%)
Updated
Aug 29 closing price
Capitalization
125.95M
Interact to see
Advertisement

ARRY vs INO

Header iconARRY vs INO Comparison
Open Charts ARRY vs INOBanner chart's image
Array Technologies
Price$9.01
Change-$0.10 (-1.10%)
Volume$2.8M
Capitalization1.38B
Inovio Pharmaceuticals
Price$2.37
Change-$0.09 (-3.66%)
Volume$1.2M
Capitalization125.95M
ARRY vs INO Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. INO commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and INO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (ARRY: $9.01 vs. INO: $2.37)
Brand notoriety: ARRY: Not notable vs. INO: Notable
ARRY represents the Alternative Power Generation, while INO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARRY: 32% vs. INO: 50%
Market capitalization -- ARRY: $1.38B vs. INO: $125.95M
ARRY [@Alternative Power Generation] is valued at $1.38B. INO’s [@Biotechnology] market capitalization is $125.95M. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Alternative Power Generation] industry is $1.86B. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, ARRY is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while INO’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 5 bearish.
  • INO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INO is a better buy in the short-term than ARRY.

Price Growth

ARRY (@Alternative Power Generation) experienced а -0.66% price change this week, while INO (@Biotechnology) price change was +20.92% for the same time period.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -4.08%. For the same industry, the average monthly price growth was +1.71%, and the average quarterly price growth was +37.17%.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

ARRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Alternative Power Generation (-4.08% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($1.38B) has a higher market cap than INO($126M). ARRY YTD gains are higher at: 49.172 vs. INO (33.146). INO has higher annual earnings (EBITDA): -84.73M vs. ARRY (-127.81M). ARRY has more cash in the bank: 377M vs. INO (47.5M). INO has less debt than ARRY: INO (10.7M) vs ARRY (694M). ARRY has higher revenues than INO: ARRY (1.17B) vs INO (182K).
ARRYINOARRY / INO
Capitalization1.38B126M1,092%
EBITDA-127.81M-84.73M151%
Gain YTD49.17233.146148%
P/E Ratio56.91N/A-
Revenue1.17B182K643,407%
Total Cash377M47.5M794%
Total Debt694M10.7M6,486%
FUNDAMENTALS RATINGS
ARRY vs INO: Fundamental Ratings
ARRY
INO
OUTLOOK RATING
1..100
2330
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3739
P/E GROWTH RATING
1..100
27100
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (71) in the Medical Specialties industry is in the same range as ARRY (93) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ARRY (100) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

INO's SMR Rating (99) in the Medical Specialties industry is in the same range as ARRY (100) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (37) in the Biotechnology industry is in the same range as INO (39) in the Medical Specialties industry. This means that ARRY’s stock grew similarly to INO’s over the last 12 months.

ARRY's P/E Growth Rating (27) in the Biotechnology industry is significantly better than the same rating for INO (100) in the Medical Specialties industry. This means that ARRY’s stock grew significantly faster than INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYINO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 23 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTALF0.49N/A
+0.60%
PetroTal Corp.
IVFH0.75N/A
N/A
Innovative Food Holdings, Inc.
NVGLF0.11N/A
N/A
NV Gold Corp
TNABY12.99N/A
N/A
Tenaga Nasional Berhad
VIVHY3.51-0.06
-1.68%
Vivendi SE

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been loosely correlated with NXT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ARRY jumps, then NXT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
-1.10%
NXT - ARRY
63%
Loosely correlated
-1.25%
RUN - ARRY
57%
Loosely correlated
-2.44%
FSLR - ARRY
56%
Loosely correlated
-0.93%
SHLS - ARRY
56%
Loosely correlated
-1.21%
CSIQ - ARRY
53%
Loosely correlated
+2.84%
More

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with AXON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
-3.66%
AXON - INO
53%
Loosely correlated
-4.43%
KROS - INO
53%
Loosely correlated
-0.26%
ARRY - INO
52%
Loosely correlated
-1.10%
RPTX - INO
52%
Loosely correlated
+0.60%
ALNY - INO
42%
Loosely correlated
-1.29%
More